Source: Annual Congress 2007 - Sarcoidosis: various aspects
Disease area: Interstitial lung diseases



Rating:

Share or cite this content

Citations should be made in the following way:
J. Videnovic-Ivanov, V. Vucinic, S. Filipovic, V. Zugic, J. Stojsic (Belgrade, Serbia And Montenegro). The role of CRP as the activity marker during the course of sarcoidosis. Eur Respir J 2007; 30: Suppl. 51, 794

Member's Comments

No comment yet.

Related content which might interest you: Elevated circulating concentrations of adiponectin in sarcoidosis – a new marker of disease? Source: Annual Congress 2006 - Clinical features and disease markers of sarcoidosis Year: 2006 Serum C-reactive protein concentrations in patients with sarcoidosis: can be taken this simple test as an activation marker in sarcoidosis? Source: Eur Respir J 2004; 24: Suppl. 48, 712s Year: 2004 The importance of inflammatory markers in sarcoidosis Source: Annual Congress 2008 - Sarcoidosis and other interstitial lung diseases Year: 2008 SP-A and CC-16 expression in COPD patient: correlation with stage of severity and possible pathogenetic role Source: Eur Respir J 2003; 22: Suppl. 45, 77s Year: 2003 The serum levels of endothelin (ET-1); an activation marker and prognostic indicator in sarcoidosis? Source: Eur Respir J 2005; 26: Suppl. 49, 80s Year: 2005 Relationship between macrophage inflammatory protein-3β(MIP-3β) levels and clinical course of sarcoidosis Source: Eur Respir J 2002; 20: Suppl. 38, 173s Year: 2002 The markers of inflammatory process activity and fybrogenesis activity in patients with idiopathic pulmonary fibrosis Source: Annual Congress 2012 - Diffuse parenchymal lung disease I Year: 2012 The role of inflammatory biomarkers like precursors of COPD stability during long-term follow-up Source: International Congress 2019 – Research and innovation in airway diseases Year: 2019 BALF TNFα level in relation to inflammatory status and phenotype of sarcoidosis Source: Annual Congress 2012 - Cystic lung diseases: lung granulomatosis Year: 2012 Serum biomarkers in SSc-ILD: association with presence, severity and prognosis Source: International Congress 2019 – From biomarkers to treatment of immune-mediated interstitial lung disease: what’s new? Year: 2019 Is YKL-40 a prognostic marker in sarcoidosis? Source: Annual Congress 2010 - Biomarkers in diffuse parenchymal lung disease Year: 2010 Serum interleukin 18 as a monitoring marker of long clinical course of pulmonary sarcoidosis Source: Eur Respir J 2004; 24: Suppl. 48, 711s Year: 2004 The role of systemic markers of inflammation in bronchiectasis. Source: International Congress 2019 – Phenotypes and endotypes of bronchiectasis Year: 2019 The relationship between level of C-reactive protein in blood serum and clinical manifestations of the disease in patients with pulmonary tuberculosis Source: Annual Congress 2010 - Tuberculosis: metabolic insights Year: 2010 The evaluation of serum biomarkers in patients with sarcoidosis: Can visfatin be a new biomarker for sarcoidosis? Source: International Congress 2017 – Rare diseases Year: 2017 The role of serum cathepsin S levels in sarcoidosis Source: Annual Congress 2010 - Biomarkers in diffuse parenchymal lung disease Year: 2010 Hepatic function markers in COPD as a systemic implication of the disease Source: Annual Congress 2008 - Functionality and metabolism in rehabilitation candidates Year: 2008 Study on levels of high sensitivity C reactive protein in asthmatic patients during exacerbation and remission and its correlation with pulmonary function Source: Annual Congress 2007 - Mechanisms of airway inflammation Year: 2007 Frequently used inflammation markers and their role in monitoring tuberculosis treatment Source: Annual Congress 2008 - Diagnosis of tuberculosis: problems and perspectives Year: 2008 Angiogenic activity of sera from tuberculosis and sarcoidosis patients in relation to IL-12 and TNFα serum level Source: Annual Congress 2003 - Genetics and immunobiology of tuberculosis Year: 2003